Sustainability & Climate

With a new $9.5M facility from SVB, Realta Fusion is accelerating its unique magnetic mirror tech to bring on-site, carbon-free power to heavy industry.

The American Diabetes Association is funding seven visionary scientists using AI, CRISPR, and stem cells to forge the next frontier in diabetes treatment.

With new Series A funding, Daffodil Health's AI platform aims to dismantle the opaque, costly systems that drive up U.S. healthcare spending.

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

Two Pasco County communities are among the nation's top sellers. Their secret? A 15-acre lagoon, a residential farm, and a new vision for community life.

Transaction Network Services launches a self-service portal, giving firms direct control to combat the spiraling, multi-billion-dollar expense of market data.

Security giant Senstar finalizes its acquisition of 3D LiDAR innovator Blickfeld, a strategic move set to revolutionize security with smarter detection.

A $1.2M grant from JUUL settlement funds will empower teens to lead prevention efforts, turning corporate accountability into youth-led community action.

A partnership between NSA Labs and Proscia is slashing study times for brain research, showing how digital platforms are key to finding new therapies faster.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

Facing a tech shortage & vehicle complexity, Autoshop Answers launches a national virtual training series to arm repair shops with critical new skills.

A new report crowns a Chicago interchange America's worst traffic chokepoint, revealing how worsening gridlock costs the U.S. economy $109 billion annually.

Watchmaker Genomics is repurposing CRISPR, not for editing genes, but to make DNA sequencing faster, cheaper, and more reliable than ever before.

A new oral drug from Nimbus Therapeutics uses AI-driven precision to fight inflammation and repair tissue, offering new hope for millions with IBD.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

Weyerhaeuser previews Trus Joist® ProPanel™ and AeroStrand™ LSL, new engineered wood products designed to cut costs and improve quality for builders.

A partial DHS shutdown deepens as Democrats demand major reforms to ICE operations, sparking a fierce debate over national security and civil liberties.

A new supply agreement for the rare isotope Actinium-225 between NorthStar and BIOEMTECH promises to break a critical bottleneck in radiopharmaceutical R&D.

A new series from A3 and BBC StoryWorks moves beyond efficiency to show how automation is augmenting human lives in healthcare, education, and more.